Nabriva Therapeutics plc Business Finance Contracts & Agreements
20 Contracts & Agreements
- Assignment Agreements (1 contract)
- Loan Agreements (5)
- Purchase Agreements (6)
- Registration Rights Agreements (1)
- Stock Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (4)
- Asset Purchase Agreement, dated as of July 30, 2023, by and among Nabriva Therapeutics plc, Nabriva Therapeutics Ireland DAC, Nabriva Therapeutics US, Inc., Nabriva Therapeutics... (Filed With SEC on July 31, 2023)
- Purchase Agreement dated September 24, 2021 between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC (Filed With SEC on September 27, 2021)
- Registration Rights Agreement dated September 24, 2021 between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC (Filed With SEC on September 27, 2021)
- Assignment, Assumption and Novation agreement, by and among Nabriva Therapeutics Ireland Designated Activity Company, Nabriva Therapeutics GmbH, Roivant Sciences Ltd., Roivant... (Filed With SEC on August 5, 2021)
- Fourth Amendment to Loan and Security Agreement, dated as of June 2, 2021, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated... (Filed With SEC on August 5, 2021)
- Form of Securities Purchase Agreement, dated March 1, 2021, by and among Nabriva Therapeutics plc and the purchasers party thereto (Filed With SEC on March 1, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on March 1, 2021)
- Form of Ordinary Share Warrant (Filed With SEC on March 1, 2021)
- Form of Securities Purchase Agreement, dated December 10, 2020, by and among Nabriva Therapeutics plc and the purchasers party thereto (Filed With SEC on December 14, 2020)
- Form of Securities Purchase Agreement, dated May 29, 2020, by and among Nabriva Therapeutics plc and the purchasers party thereto (Filed With SEC on June 1, 2020)
- Form of Warrant (Filed With SEC on June 1, 2020)
- Third Amendment to Loan and Security Agreement, dated as of March 11, 2020, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated... (Filed With SEC on March 12, 2020)
- Second Amendment to Loan and Security Agreement, dated as of January 8, 2020, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated... (Filed With SEC on March 12, 2020)
- Form of Securities Purchase Agreement, dated December 20, 2019, by and among Nabriva Therapeutics plc and the purchasers party thereto (Filed With SEC on December 20, 2019)
- Form of Warrant (Filed With SEC on December 20, 2019)
- First Amendment to Loan and Security Agreement, dated as of September 26, 2019, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated... (Filed With SEC on November 12, 2019)
- Loan and Security Agreement, dated as of December 20, 2018, by and among Nabriva Therapeutics plc, Nabriva Therapeutics Ireland DAC, certain other subsidiaries of Nabriva... (Filed With SEC on March 12, 2019)
- Stock Purchase Agreement by and among SG Pharmaceuticals, Inc., the Sellers named on Annex A, and Julia Feliciano, as Sellers Representative, dated as of May 5, 2015 (Filed With SEC on November 6, 2018)
- Underwriting Agreement, dated July 26, 2018, by and among Nabriva Therapeutics plc and Morgan Stanley & Co. LLC, as representative of the underwriters named therein (Filed With SEC on August 1, 2018)
- Underwriting Agreement, dated September 19, 2017, by and among Nabriva Therapeutics plc and Morgan Stanley & Co. LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as... (Filed With SEC on September 20, 2017)
